Catherine Kinney - MetLife Independent Director
| MET Stock | USD 82.36 0.36 0.44% |
Director
Ms. Catherine R. Kinney is an Independent Director of MetLife Inc. Ms. Kinney is a Former President and CoChief Operating Officer, New York Stock Exchange, Inc. Ms. Kinneys experience as a senior executive and chief operating officer of a multinational, regulated entity, her key role in transforming the New York Stock Exchange to a publicly held company, and her leadership in developing and establishing the NYSE corporate governance standards for its listed companies demonstrate her knowledge of and experience with issues of corporate development, transformation and governance. These qualities are relevant to ensuring that the Board establishes and maintains effective governance structures appropriate for a global provider of insurance and financial products and services since 2009.
| Age | 69 |
| Tenure | 16 years |
| Address | 200 Park Avenue, New York, NY, United States, 10166-0188 |
| Phone | 212 578 9500 |
| Web | https://www.metlife.com |
Catherine Kinney Latest Insider Activity
Tracking and analyzing the buying and selling activities of Catherine Kinney against MetLife stock is an integral part of due diligence when investing in MetLife. Catherine Kinney insider activity provides valuable insight into whether MetLife is net buyers or sellers over its current business cycle. Note, MetLife insiders must abide by specific rules, including filing SEC forms every time they buy or sell MetLife'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
Catherine Kinney over three months ago Acquisition by Catherine Kinney of 594 shares of MetLife subject to Rule 16b-3 | ||
Catherine Kinney over six months ago Acquisition by Catherine Kinney of 23051 shares of SolarWinds Corp subject to Rule 16b-3 | ||
Catherine Kinney over a year ago Acquisition by Catherine Kinney of tradable shares of MSCI subject to Rule 16b-3 |
MetLife Management Efficiency
Return On Equity is likely to gain to 0.17 in 2025, whereas Return On Tangible Assets are likely to drop 0 in 2025. Change To Liabilities is likely to gain to about 5.4 B in 2025, whereas Total Current Liabilities is likely to drop slightly above 1.5 B in 2025. MetLife's management efficiency ratios could be used to measure how well MetLife manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | DIRECTOR Age | ||
| Theodore Bunting | Unum Group | 62 | |
| Karole Lloyd | Aflac Incorporated | 62 | |
| George Sartorel | Prudential PLC ADR | 63 | |
| Sock Chua | Prudential PLC ADR | 63 | |
| Robert Greving | CNO Financial Group | 69 | |
| Gilbert Casellas | Prudential Financial | 68 | |
| Sandra Pianalto | Prudential Financial | 66 | |
| Jonathan Oliver | Prudential PLC ADR | N/A | |
| Ronalee Ambrose | Manulife Financial Corp | 49 | |
| Melvin Stith | Aflac Incorporated | 74 | |
| Jeremy Anderson | Prudential PLC ADR | 63 | |
| Francis Shammo | Unum Group | 59 | |
| Douglas Scovanner | Prudential Financial | 65 | |
| Julie Dickson | Manulife Financial Corp | 63 | |
| Tsunyan Hsieh | Manulife Financial Corp | 67 | |
| Thomas Kenny | Aflac Incorporated | 57 | |
| Steven Shebik | CNO Financial Group | 64 | |
| Dale LeFebvre | Lincoln National | 53 | |
| Susan DeVore | Unum Group | 62 | |
| Kaikhushru Nargolwala | Prudential PLC ADR | 69 | |
| Patrick Pittard | Lincoln National | 74 | |
Management Performance
| Return On Equity | 0.15 | |||
| Return On Asset | 0.0051 |
MetLife Leadership Team
Elected by the shareholders, the MetLife's board of directors comprises two types of representatives: MetLife inside directors who are chosen from within the company, and outside directors, selected externally and held independent of MetLife. The board's role is to monitor MetLife's management team and ensure that shareholders' interests are well served. MetLife's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, MetLife's outside directors are responsible for providing unbiased perspectives on the board's policies.
| MBA BS, Chief VP | ||
| Eric Clurfain, Regional America | ||
| Catherine Kinney, Independent Director | ||
| Randolph Clerihue, Chief Officer | ||
| Carlos Gutierrez, Independent Director | ||
| Michael Roberts, Executive Vice President Chief Marketing Officer | ||
| Michael Zarcone, Head CEO | ||
| Pawan Verma, Executive Vice President, Chief Information Officer | ||
| Stephen Gauster, Senior Vice President Interim General Counsel | ||
| Wayne Daniel, Senior Pensions | ||
| Ramy Tadros, Executive Vice President and President - U.S. Business | ||
| Michel Khalaf, President, Chief Executive Officer, Director | ||
| Shurawl Sibblies, Executive Officer | ||
| Bill Pappas, Executive Vice President Head of Global Technology and Operations | ||
| Toby Brown, Interim VP | ||
| Diana McKenzie, Independent Director | ||
| Randy Stram, Senior Benefits | ||
| Cheryl Grise, Lead Independent Director | ||
| William ODonnell, EVP CFO | ||
| Susan MBA, Executive Officer | ||
| John Hall, Senior Relations | ||
| Robert Hubbard, Independent Chairman of the Board | ||
| William Kennard, Independent Director | ||
| Steven Goulart, Executive Vice President, Chief Investment Officer | ||
| Susan Podlogar, Chief Human Resource Officer, Executive Vice President | ||
| Robert Merck, Global MD | ||
| David Herzog, Independent Director | ||
| Cindy Pace, Global Chief Diversity and Inclusion Officer | ||
| Bharat Kannan, Chief Asia | ||
| Robin Gordon, Chief Data and Analytics Officer | ||
| William Moore, President Business | ||
| Esther Lee, Executive Vice President Global Chief Marketing Officer | ||
| Edward Kelly, Independent Director | ||
| Gerald Hassell, Independent Director | ||
| Oscar Schmidt, President of Latin America | ||
| Sue Elliott, Head Benefits | ||
| Michael Farrell, Head EVP | ||
| Denise Morrison, Independent Director | ||
| Nuria Garcia, Head of EMEA | ||
| Monica Curtis, Executive Officer | ||
| Marlene Debel, Executive Vice President, Chief Risk Officer | ||
| Mark Weinberger, Independent Director | ||
| John McCallion, Chief Financial Officer, Executive Vice President | ||
| Kishore Ponnavolu, President - Asia Region | ||
| John CPA, Executive CFO |
MetLife Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is MetLife a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.15 | |||
| Return On Asset | 0.0051 | |||
| Profit Margin | 0.06 % | |||
| Operating Margin | 0.05 % | |||
| Current Valuation | 71.88 B | |||
| Shares Outstanding | 681.23 M | |||
| Shares Owned By Insiders | 16.51 % | |||
| Shares Owned By Institutions | 76.25 % | |||
| Number Of Shares Shorted | 7.36 M | |||
| Price To Earning | 28.61 X |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for MetLife Stock Analysis
When running MetLife's price analysis, check to measure MetLife's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MetLife is operating at the current time. Most of MetLife's value examination focuses on studying past and present price action to predict the probability of MetLife's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MetLife's price. Additionally, you may evaluate how the addition of MetLife to your portfolios can decrease your overall portfolio volatility.